[Reversible posterior leukoencephalopathy syndrome in a patient presenting granulomatosis with polyangiitis]

L Chaput1, N Rabot2, N Limousin3

  • 1Service de dermatologie, université François-Rabelais, CHU de Tours, avenue de la République, 37170 Chambray-Les-Tours, France.

Abstract

Insights

Reversible posterior leukoencephalopathy syndrome (RPLS) is rare in systemic vasculitis. Prompt management of high blood pressure in patients treated with corticosteroids for vasculitis is crucial for preventing RPLS.

Area of Science:

  • Neurology
  • Immunology
  • Radiology

Background:

  • Reversible posterior leukoencephalopathy syndrome (RPLS) presents with neurological symptoms and characteristic MRI findings.
  • RPLS is occasionally associated with autoimmune diseases and systemic vasculitis.
  • Granulomatosis with polyangiitis (Wegener's granulomatosis) is a rare cause of RPLS.

Observation:

  • A 22-year-old female with granulomatosis with polyangiitis developed seizures, blindness, and confusion after corticosteroid treatment.
  • The patient experienced hypertension and acute renal failure.
  • Brain MRI showed T2-Flair hyperintensities in the occipital-temporal lobes.

Findings:

  • The patient's neurological and radiological findings were reversible with treatment.
  • Treatment included antiepileptics, antihypertensives, oral steroids, and cyclophosphamide.
  • This case highlights the potential for RPLS in granulomatosis with polyangiitis.

Implications:

  • RPLS is a rare but serious complication of systemic vasculitis.
  • Monitoring blood pressure in vasculitis patients receiving corticosteroids is vital.
  • Early detection and management of RPLS can lead to favorable outcomes.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...